Adults with persistent asthma may be at increased risk of heart attack or stroke because of excess plaque buildup in the carotid arteries, according to new research published today in the Journal of the American Heart Association, ...
Nov 23, 2022
0
3
The brains of people with Down syndrome develop the same neurodegenerative tangles and plaques associated with Alzheimer's disease and frequently demonstrate signs of the neurodegenerative disorder in their forties or fifties. ...
Nov 18, 2022
0
115
Cedars-Sinai investigators and colleagues have developed an artificial intelligence (AI) tool that uses computed tomography (CT) scans to identify patients at risk of reduced blood flow to the heart. The tool is able to accurately ...
Nov 14, 2022
0
5
In Alzheimer's disease, the degeneration of brain cells is linked to formation of toxic protein aggregates and deposits known as amyloid plaques. Similar processes also play an important role in type 2 diabetes. A research ...
Nov 9, 2022
0
1142
Indiana University School of Medicine researchers are investigating how the deficiency of a gene in immune cells can shape the progression of Alzheimer's disease.
Nov 3, 2022
0
66
An estimated 6.2 million Americans ages 65 and older are living with Alzheimer's disease. The national Alzheimer's Association predicts that number to grow to 13.8 million by 2060, barring the development of medical breakthroughs ...
Nov 2, 2022
0
58
Alzheimer's disease is the sixth leading cause of death in the United States, affecting more than 6 million Americans, and its incidence is expected to rise in the coming decades.
Nov 2, 2022
0
94
Atherosclerosis, the clogging of the arteries with fatty plaques, is a major cause of death worldwide. Human atherosclerosis often involves calcification (or a build-up of calcium) in the arteries, and thrombosis, where a ...
Oct 27, 2022
1
34
The overexpression of a gene tied to cell division and the structure and function of neurons may prevent and protect against cognitive decline in both mice and humans with Alzheimer's disease (AD), according to a new study ...
Oct 25, 2022
0
64
Partner companies Eisai and Biogen recently announced promising clinical trial results for their new Alzheimer's drug lecanemab. Over 18 months, patients treated with lecanemab experienced slower symptom progression than ...
Oct 14, 2022
0
5
